157 related articles for article (PubMed ID: 22702645)
1. Soluble CD40L in children and adolescents with type 1 diabetes: relation to microvascular complications and glycemic control.
El-Asrar MA; Adly AA; Ismail EA
Pediatr Diabetes; 2012 Dec; 13(8):616-24. PubMed ID: 22702645
[TBL] [Abstract][Full Text] [Related]
2. Assessment of serum levels of soluble CD40L in Egyptian children and adolescents with type 1 diabetes mellitus: Relationship to microalbuminuria and glycemic control.
Metwalley KA; Farghaly HS; El-Saied AR
Indian J Endocrinol Metab; 2013 Nov; 17(6):1024-9. PubMed ID: 24381879
[TBL] [Abstract][Full Text] [Related]
3. Ferritin levels in children and adolescents with type 1 diabetes mellitus: relationship with microvascular complications and glycemic control.
Metwalley KA; Raafat DM; Tamer DM; Farghaly HS; Said GM
Arch Endocrinol Metab; 2021 May; 64(6):720-725. PubMed ID: 34033281
[TBL] [Abstract][Full Text] [Related]
4. Increased concentrations of soluble CD40 ligand may help to identify type 1 diabetic adolescents and young adults at risk for developing persistent microalbuminuria.
Chiarelli F; Giannini C; Verrotti A; Mezzetti A; Mohn A
Diabetes Metab Res Rev; 2008 Oct; 24(7):570-6. PubMed ID: 18756582
[TBL] [Abstract][Full Text] [Related]
5. Kallistatin as a marker of microvascular complications in children and adolescents with type 1 diabetes mellitus: Relation to carotid intima media thickness.
El-Asrar MA; Andrawes NG; Ismail EA; Salem SM
Vasc Med; 2015 Dec; 20(6):509-17. PubMed ID: 26091968
[TBL] [Abstract][Full Text] [Related]
6. Enhanced levels of soluble CD40 ligand and C-reactive protein in a total of 312 patients with metabolic syndrome.
Unek IT; Bayraktar F; Solmaz D; Ellidokuz H; Yuksel F; Sisman AR; Yesil S
Metabolism; 2010 Mar; 59(3):305-13. PubMed ID: 20006362
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor (VEGF) in children, adolescents and young adults with Type 1 diabetes mellitus: relation to glycaemic control and microvascular complications.
Chiarelli F; Spagnoli A; Basciani F; Tumini S; Mezzetti A; Cipollone F; Cuccurullo F; Morgese G; Verrotti A
Diabet Med; 2000 Sep; 17(9):650-6. PubMed ID: 11051284
[TBL] [Abstract][Full Text] [Related]
8. Enhanced soluble CD40 ligand contributes to endothelial cell dysfunction in vitro and monocyte activation in patients with diabetes mellitus: effect of improved metabolic control.
Cipollone F; Chiarelli F; Davì G; Ferri C; Desideri G; Fazia M; Iezzi A; Santilli F; Pini B; Cuccurullo C; Tumini S; Del Ponte A; Santucci A; Cuccurullo F; Mezzetti A
Diabetologia; 2005 Jun; 48(6):1216-24. PubMed ID: 15868137
[TBL] [Abstract][Full Text] [Related]
9. Endothelial monocyte activating polypeptide II in children and adolescents with type 1 diabetes mellitus: Relation to micro-vascular complications.
Adly AAM; Ismail EA; Tawfik LM; Ebeid FSE; Hassan AAS
Cytokine; 2015 Dec; 76(2):156-162. PubMed ID: 26142824
[TBL] [Abstract][Full Text] [Related]
10. Association of soluble CD40 ligand with carotid atherosclerosis in Japanese type 1 diabetic patients.
Katakami N; Kaneto H; Matsuhisa M; Miyatsuka T; Sakamoto K; Kawamori D; Yoshiuchi K; Nakamura Y; Kato K; Yamamoto K; Kosugi K; Hori M; Yamasaki Y
Diabetologia; 2006 Jul; 49(7):1670-6. PubMed ID: 16752185
[TBL] [Abstract][Full Text] [Related]
11. Advanced glycation end products in children and adolescents with diabetes: relation to glycemic control and early microvascular complications.
Chiarelli F; de Martino M; Mezzetti A; Catino M; Morgese G; Cuccurullo F; Verrotti A
J Pediatr; 1999 Apr; 134(4):486-91. PubMed ID: 10190925
[TBL] [Abstract][Full Text] [Related]
12. Soluble CD40 ligand, platelet surface CD40 ligand, and total platelet CD40 ligand in atrial fibrillation: relationship to soluble P-selectin, stroke risk factors, and risk factor intervention.
Choudhury A; Chung I; Panja N; Patel J; Lip GYH
Chest; 2008 Sep; 134(3):574-581. PubMed ID: 18641098
[TBL] [Abstract][Full Text] [Related]
13. Circulating angiopoietin-2 levels in children and adolescents with type 1 diabetes mellitus: relation to carotid and aortic intima-media thickness.
El-Asrar MA; Elbarbary NS; Ismail EA; Bakr AA
Angiogenesis; 2016 Jul; 19(3):421-31. PubMed ID: 27236773
[TBL] [Abstract][Full Text] [Related]
14. Elevated plasma levels of the atherogenic mediator soluble CD40 ligand in diabetic patients: a novel target of thiazolidinediones.
Varo N; Vicent D; Libby P; Nuzzo R; Calle-Pascual AL; Bernal MR; Fernández-Cruz A; Veves A; Jarolim P; Varo JJ; Goldfine A; Horton E; Schönbeck U
Circulation; 2003 Jun; 107(21):2664-9. PubMed ID: 12742991
[TBL] [Abstract][Full Text] [Related]
15. Relationship between soluble CD40 ligand and gamma-glutamyltransferase concentrations in non-drinking, young Type 1 diabetic individuals.
Zoppini G; Targher G; Trombetta M; Lippi G; Muggeo M
Diabet Med; 2008 Nov; 25(11):1283-8. PubMed ID: 19046217
[TBL] [Abstract][Full Text] [Related]
16. Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.
Cardoso CRL; Leite NC; Moram CBM; Salles GF
Cardiovasc Diabetol; 2018 Feb; 17(1):33. PubMed ID: 29477146
[TBL] [Abstract][Full Text] [Related]
17. Soluble urokinase plasminogen activator receptor in type 1 diabetic children, relation to vascular complications.
Sherif EM; El Maksood AAA; Youssef OI; Salah El-Din NY; Khater OKM
J Diabetes Complications; 2019 Sep; 33(9):628-633. PubMed ID: 31301955
[TBL] [Abstract][Full Text] [Related]
18. The relation between plasma endothelin-1 levels and metabolic control, risk factors, treatment modalities, and diabetic microangiopathy in patients with Type 2 diabetes mellitus.
Ak G; Buyukberber S; Sevinc A; Turk HM; Ates M; Sari R; Savli H; Cigli A
J Diabetes Complications; 2001; 15(3):150-7. PubMed ID: 11358684
[TBL] [Abstract][Full Text] [Related]
19. Persistent C-peptide levels and microvascular complications in childhood onset type 1 diabetes of long duration.
Williams KV; Becker DJ; Orchard TJ; Costacou T
J Diabetes Complications; 2019 Sep; 33(9):657-661. PubMed ID: 31239235
[TBL] [Abstract][Full Text] [Related]
20. Serum vaspin levels in type 2 diabetic women in relation to microvascular complications.
Gulcelik NE; Karakaya J; Gedik A; Usman A; Gurlek A
Eur J Endocrinol; 2009 Jan; 160(1):65-70. PubMed ID: 18952766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
